HIKMA Pharmaceuticals PLC
HIK | IL
Overview
Corporate Details
- ISIN(s):
- GB00B0LCW083
- LEI:
- 549300BNS685UXH4JI75
- Country:
- United Kingdom
- Address:
- 1 New Burlington Place, W1S 2HR London
- Website:
- https://www.hikma.com/home/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Hikma Pharmaceuticals PLC is a global pharmaceutical company that is dedicated to providing high-quality, affordable medications to patients worldwide. With its headquarters in London, UK, and operations in the Middle East, Africa, Europe, and the United States, Hikma has established itself as a leader in the pharmaceutical industry. The company has a diversified product portfolio that includes branded, generic, and injectable pharmaceuticals. Its focus is on developing and manufacturing innovative solutions for complex diseases, such as oncology, respiratory, and injectables.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-09 10:00 |
Report Publication Announcement
Notice of Results
|
English | 12.9 KB | |
| 2025-07-07 10:16 |
Prospectus
Publication of Offering Circular
|
English | 8.0 KB | |
| 2025-06-05 15:05 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 14.4 KB | |
| 2025-06-03 14:02 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 89.1 KB | |
| 2025-05-29 08:00 |
Regulatory News Service
Fitch upgrades Hikma to ‘BBB’
|
English | 11.3 KB | |
| 2025-05-15 13:00 |
Regulatory News Service
Medium-term Group guidance ahead of US site visit
|
English | 12.5 KB | |
| 2025-05-08 11:48 |
Regulatory News Service
S&P upgrades Hikma to ‘BBB’
|
English | 11.3 KB | |
| 2025-05-08 09:21 |
Legal Proceedings Report
Settlement agreement for Xyrem® US lawsuits
|
English | 15.2 KB | |
| 2025-04-30 14:21 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 27.3 KB | |
| 2025-04-24 18:16 |
Declaration of Voting Results & Voting Rights Announcements
Special Business passed at AGM
|
English | 329.0 KB | |
| 2025-04-24 16:55 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 48.9 KB | |
| 2025-03-19 11:10 |
Report Publication Announcement
Annual Financial Report and Notice of AGM
|
English | 10.4 KB | |
| 2025-03-19 11:10 |
General Meeting Notice
Notice of 2025 Annual General Meeting
|
English | 827.6 KB | |
| 2025-03-19 11:07 |
Annual Report (ESEF)
2024 Annual Report and Accounts
|
English | 9.8 MB | |
| 2025-03-19 11:07 |
Annual Report
2024 Annual Report and Accounts
|
English | 18.6 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |